British Journal of Haematology, 0007-1048

Journal

More filtering options
  1. Improved outcome after relapse in children with acute myeloid leukaemia

    Abrahamsson, J., Clausen, N., Gustafsson, G., Hovi, L., Jonmundsson, G., Zeller, B., Forestier, E., Heldrup, J. & Hasle, H., 2007, In : British Journal of Haematology. 136, 2, p. 229-236

    Research output: Contribution to journalArticle

  2. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.

    Andersen, M. K., Autio, K., Barbany, G., Borgström, G., Cavelier, L., Golovleva, I., Heim, S., Heinonen, K., Hovland, R., Johannsson, J. H., Bertil Johansson, Kjeldsen, E., Nordgren, A., Palmqvist, L. & Forestier, E., 2011, In : British Journal of Haematology. 155, p. 235-243

    Research output: Contribution to journalArticle

  3. Long term risk of infections in Hodgkin lymphoma long-term survivors.

    Andersson, A., Enblad, G., Gustavsson, A., Erlanson, M., Hagberg, H., Molin, D., Tavelin, B. & Melin, B., 2011, In : British Journal of Haematology. 154, p. 661-663

    Research output: Contribution to journalLetter

  4. Towards a better understanding and new therapeutics of osteopetrosis.

    Askmyr, M. K., Fasth, A. & Johan Richter, 2008, In : British Journal of Haematology. 140, 6, p. 597-609

    Research output: Contribution to journalReview article

  5. Splenic lymphocyte subtypes in immune thrombocytopenia: increased presence of a subtype of B-regulatory cells

    Aslam, R., Segel, G. B., Burack, R., Spence, S. A., Speck, E. R., Guo, L. & John W Semple, 2016 Apr, In : British Journal of Haematology. 173, 1, p. 159-60 2 p.

    Research output: Contribution to journalArticle

  6. Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells

    Aslam, R., Burack, W. R., Segel, G. B., McVey, M. J., Spence, S. A. & John W. Semple, 2018, In : British Journal of Haematology. 181, p. 262-264

    Research output: Contribution to journalLetter

  7. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

    Jan Astermark, Petrini, P., Tengborn, L., Schulman, S., Rolf Ljung & Erik Berntorp, 1999, In : British Journal of Haematology. 105, 4, p. 1109-1113

    Research output: Contribution to journalArticle

  8. Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.

    Jan Astermark, Ekman, M. & Erik Berntorp, 2002, In : British Journal of Haematology. 119, 2, p. 342-347

    Research output: Contribution to journalArticle

  9. Major surgery seems not to influence HIV disease progression in haemophilia patients

    Jan Astermark, Löfqvist, T., Schulman, S., Stigendal, L., Lethagen, S., Nilsson, I. M. & Erik Berntorp, 1998, In : British Journal of Haematology. 103, 1, p. 10-14

    Research output: Contribution to journalArticle

  10. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden

    Bermejo, J. L., Pukkala, E., Johannesen, T. B., Jan Sundquist & Kari Hemminki, 2014, In : British Journal of Haematology. 164, 5, p. 675-683

    Research output: Contribution to journalArticle

  11. Monoclonal gammopathy of undetermined significance: to screen or not to screen for multiple myeloma? - response

    Bird, J., Behrens, J., Drayson, M. T., Ingemar Turesson & Westin, J., 2010, In : British Journal of Haematology. 149, 4, p. 621-623

    Research output: Contribution to journalLetter

  12. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

    Bird, J., Behrens, J., Westin, J., Ingemar Turesson, Drayson, M., Beetham, R., D'Sa, S., Soutar, R., Waage, A., Gulbrandsen, N., Gregersen, H. & Low, E., 2009, In : British Journal of Haematology. 147, 1, p. 22-42

    Research output: Contribution to journalArticle

  13. Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts

    Borrow, J., Goddard, A. D., Gibbons, B., Katz, F., Swirsky, D., Thoas Fioretos, Dube, I., Winfield, D. A., Kingston, J., Hagemeijer, A., Rees, J. K. H., Lister, T. A. & Solomon, E., 1992, In : British Journal of Haematology. 82, 3, p. 529-540

    Research output: Contribution to journalArticle

  14. The impact of bleeding history, von Willebrand factor and PFA-100 (R) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD

    Castaman, G., Tosetto, A., Goodeve, A., Federici, A. B., Lethagen, S., Budde, U., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Ingerslev, J., Habart, D., Hill, F., Peake, I. & Rodeghiero, F., 2010, In : British Journal of Haematology. 151, 3, p. 245-251

    Research output: Contribution to journalArticle

  15. Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T -> C promoter mutation in non-erythroid tissues

    Chaudhuri, A., Yuen, G., Fang, F. & Jill Storry, 2004, In : British Journal of Haematology. 127, 3, p. 356-359

    Research output: Contribution to journalArticle

  16. Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk

    Crowther-Swanepoel, D., Mansouri, M., Enjuanes, A., Vega, A., Smedby, K. E., Ruiz-Ponte, C., Jurlander, J., Gunnar Juliusson, Montserrat, E., Catovsky, D., Campo, E., Carracedo, A., Rosenquist, R. & Houlston, R. S., 2010, In : British Journal of Haematology. 150, 4, p. 473-479

    Research output: Contribution to journalArticle

  17. Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

    d'Amore, F., Radford, J., Relander, T., Mats Jerkeman, Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H., 2010, In : British Journal of Haematology. 150, 5, p. 565-573

    Research output: Contribution to journalArticle

  18. Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

    Dang, N. H., Ogura, M., Castaigne, S., Fayad, L. E., Mats Jerkeman, Radford, J., Pezzutto, A., Bondarenko, I. N., Stewart, D. A., Shnaidman, M., Sullivan, S., Vandendries, E., Tobinai, K., Ramchandren, R., Hamlin, P. A., Giné, E. & Ando, K., 2018, In : British Journal of Haematology. 182, 4, p. 583-586

    Research output: Contribution to journalDebate/Note/Editorial

  19. Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c-Kit stimulation

    Edling, C. E., Pedersen, M., Carlsson, L., Lars Rönnstrand, Palmer, R. H. & Hallberg, B., 2007, In : British Journal of Haematology. 136, 2, p. 260-268

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 Next